biotech, pharma, drug development

The state’s industry draws inspiration from medicine as well as agriculture.

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.
 

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
 

Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.

Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.

An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.

GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.

Pharmaceutical companies should deploy cash to fund struggling biotech companies, which could generate much needed new drugs.

A roundup of eight biotech companies that didn’t make it through this year's continuing tough economic times